EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design

Maria A Nikiforova iD, Sergei Y Grishin iD, Anna Y Aksenova iD, Evgeniya I Deryusheva iD, Ilya V Likhachev iD, Roman S Fadeev, Margarita I Kobyakova iD, Alexey P Kochetov iD, Alexey K Surin iD, Vladimir A Gushchin, Oxana V Galzitskaya iD

International Journal of Molecular Sciences · 28.07.2026 · 27 (15) · 6751

DOI: 10.3390/ijms27156751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.07.2026. Verfasst von Maria A Nikiforova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antiviral Agents, Peptide Fragments. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State assignment for the Institute of Protein Research of the Russian Academy of Sciences, St. Petersburg State University, Institute of Theoretical and Experimental Biology of the Russian Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein remains a central target for antiviral drug development. Recent in silico studies have revealed an expansion of amyloidogenic regions within the RBD of the Omicron variant, raising the possibility that amyloid-prone peptide fragments could modulate Spike function or host–virus interactions. In this study, we combined experimental assays with multiscale computational modeling to systematically characterise two short RBD-derived peptides: Pep-2 (YFPLQSYGFQ) from the ancestral Wuhan strain and Pep-3 (YFPLRSYSFR) from the Omicron BA.1 variant, the latter being predicted to have higher amyloidogenic potential. Cell-based assays demonstrated that neither peptide exhibited intrinsic cytotoxic or cytostatic effects on human lung fibroblasts or A549 lung adenocarcinoma cells at physiologically relevant concentrations, whereas significant cytotoxicity was observed in Vero E6 cells. In infection models with the B.1.1.1 (Wuhan) and BA.1 (Omicron) variants, the peptides unexpectedly enhanced virus-induced cytopathic effects at lower concentrations but inhibited viral infection at higher concentrations, indicating to a dose-dependent modulatory role for these short amyloidogenic RBD fragments. Fluorescence spectroscopy measurements did not detect the formation of stable thioflavin-T-positive amyloid fibrils. Computational analyses revealed that both peptides interact with the Spike RBD via multiple energetically favorable yet spatially heterogeneous modes, mostly outside the ACE2-binding site. Moreover, their predicted binding affinities for the ACE2 receptor were comparable, suggesting an additional route of interaction via the host receptor. Collectively, our findings demonstrate that these short amyloidogenic RBD-derived peptides exert a complex antiviral profile, with their interactions with both viral and host factors potentially shaping infection outcomes. This highlights the importance of spatially targeted and conformationally constrained peptide designs to effectively harness amyloidogenic features for antiviral therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Antiviral AgentsPeptide FragmentsAmyloidogenic ProteinsPeptidesHumansAnimalsVero CellsChlorocebus aethiopsDrug DesignA549 CellsCOVID-19Protein Binding

Stichwörter der Autor:innen

Omicron variantSARS-CoV-2Spike proteinamyloidogenic propertiesmolecular modellingreceptor-binding domain (RBD)

Substanzen

Spike Glycoprotein, CoronavirusAntiviral Agentsspike protein, SARS-CoV-2Peptide FragmentsAmyloidogenic ProteinsPeptides

Autor:innen und Institutionen

  • Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
  • Institute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, Russia.
  • Laboratory of Amyloid Biology, St. Petersburg State University, 199034 St. Petersburg, Russia.
  • Institute for Biological Instrumentation, Federal Research Center "Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
  • Institute of Mathematical Problems of Biology, Russian Academy of Sciences, Branch of the Keldysh Institute of Applied Mathematics, Russian Academy of Sciences, 142290 Pushchino, Russia.
  • Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia.

ORCID-Profile: Maria A Nikiforova, Sergei Y Grishin, Anna Y Aksenova, Evgeniya I Deryusheva, Ilya V Likhachev, Margarita I Kobyakova, Alexey P Kochetov, Alexey K Surin, Oxana V Galzitskaya

Förderung

  • State assignment for the Institute of Protein Research of the Russian Academy of Sciences
  • St. Petersburg State University
  • Institute of Theoretical and Experimental Biology of the Russian Academy of Sciences

Zitieren

APA

Nikiforova, M. A., Grishin, S. Y., Aksenova, A. Y., Deryusheva, E. I., Likhachev, I. V., Fadeev, R. S., Kobyakova, M. I., Kochetov, A. P., Surin, A. K., Gushchin, V. A., & Galzitskaya, O. V. (2026). Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design. International Journal of Molecular Sciences, 27(15), 6751. https://doi.org/10.3390/ijms27156751

Vancouver

Nikiforova MA, Grishin SY, Aksenova AY, Deryusheva EI, Likhachev IV, Fadeev RS, et al. Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design. International Journal of Molecular Sciences. 2026;27(15):6751. doi:10.3390/ijms27156751

BibTeX
@article{Nikiforova2026,
  author = {Nikiforova, Maria A and Grishin, Sergei Y and Aksenova, Anna Y and Deryusheva, Evgeniya I and Likhachev, Ilya V and Fadeev, Roman S and Kobyakova, Margarita I and Kochetov, Alexey P and Surin, Alexey K and Gushchin, Vladimir A and Galzitskaya, Oxana V},
  title = {Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6751},
  doi = {10.3390/ijms27156751}
}
Kostenlos starten →